全球葡萄糖酸鈣市場－2025-2030年預測

全球葡萄糖酸鈣市場預計將從 2025 年的 127,471,000 美元成長到 2030 年的 156,023,000 美元，複合年成長率為 4.13%。

葡萄糖酸鈣是一種礦物質補充劑，由葡萄糖酸與石灰或碳酸鈣中和製成。它是一種重要的治療藥物，可靜脈注射或其他途徑給藥，用於治療多種由鈣缺乏引起的疾病，包括低鈣性手足搦症、副甲狀腺功能副甲狀腺機能亢進症相關的低血鈣症、與快速生長和懷孕相關的疾病以及高鎂血症。受主要終端用戶產業（尤其是製藥和食品飲料產業）需求成長的推動，全球葡萄糖酸鈣市場預計將持續擴張。

市場成長促進因素

鈣葡萄糖酸鹽市場的主要成長要素是膳食補充劑消費量的增加。鈣補充劑在治療低血鈣症及其併發症等鈣缺乏症方面的顯著療效鞏固了市場需求。大眾對骨質疏鬆症等疾病（影響著相當一部分人口）的健康意識不斷提高，促使人們積極將鈣補充劑納入健康維護策略，從而推動了鈣葡萄糖酸鹽等產品的市場成長。

儘管看似獨立，但其他礦物質補充劑（例如葡萄糖酸銅）的消費也在影響市場格局。銅在維持心率等生理功能中發揮著至關重要的作用，而銅缺乏與心臟病密切相關。隨著全球心臟病病例以及其他與營養不良和維生素缺乏相關的健康問題日益增多，礦物質補充劑市場整體正在擴張。受營養匱乏的垃圾食物消費和飲食障礙率上升等因素的推動，這一趨勢間接地刺激了對葡萄糖酸鹽類補充劑（包括葡萄糖酸鈣）的需求。

此外，主要產業參與者之間的投資和合作策略重點也是市場發展的關鍵促進因素。為了在競爭激烈的經濟環境中維持成長，企業正集中投資於新技術引進、原物料供應保障和產品系列最佳化。鑑於各國經濟和社會環境的差異，製造商正在加速制定區域性策略，以有效滲透多元化的全球市場。

市場區隔分析

根據產品類別分類，預計乳酸葡萄糖酸鈣將佔據最大的市場佔有率。這種化合物是一種白色結晶質無味粉末，以其良好的生理相容性和無毒性而聞名。其優異的生物利用度、中性口感和極佳的溶解性使其成為理想之選。科學研究表明，與其他鈣鹽相比，它能持續顯著地提高骨骼密度。這些特性使其成為醫藥和食品加工應用中極具價值的優質鈣源，尤其是在溶解性至關重要的領域，例如透明飲料和即溶配方。

就應用領域而言，製藥業是葡萄糖酸鈣的主要應用領域。葡萄糖酸鈣在醫療方面的益處，尤其是在治療因生活方式改變和缺乏運動而引起的骨質疏鬆症方面，使其佔據了最大的市場佔有率。此外，消費者對預防鈣缺乏產品的需求不斷成長，也是推動其在製藥領域應用的關鍵因素。

區域展望

從區域來看，北美預計將成為全球葡萄糖酸鈣的主要市場，這主要得益於該地區蓬勃發展的醫療保健產業。該地區擁有眾多大型製藥企業，並且生產用於治療甲狀腺疾病和佝僂病的藥物，這些都是推動市場成長的具體因素。

同時，美國的戰略投資項目預計將進一步推動成長。由健康基金會和科學院推出的各項舉措，旨在解決全球鈣缺乏症及其對健康的影響。這些項目通常會探討補充鈣在改善健康結果（包括孕產婦健康和心血管功能）方面的作用。低鈣水平與心血管疾病風險增加之間已確立的聯繫，進一步凸顯了補充鈣的重要性，從而推動葡萄糖酸鈣作為關鍵治療和預防藥物擴大市場佔有率。

本報告的主要優勢：

• 深入分析：提供對主要和新興地區的深入市場洞察，重點關注客戶群、政府政策和社會經濟因素、消費者偏好、行業垂直領域和其他細分市場。
• 競爭格局：了解全球主要參與者的策略舉措，並了解透過正確的策略進入市場的機會。
• 市場促進因素與未來趨勢：探討影響市場的動態因素和關鍵趨勢及其對未來市場發展的影響。
• 可操作的建議：利用這些見解，在動態環境中做出策略決策，並開拓新的商機和收入來源。
• 受眾廣泛：對Start-Ups、研究機構、顧問公司、中小企業和大型企業都很有用且經濟實惠。

企業使用我們的報告做什麼？

產業與市場分析、機會評估、產品需求預測、打入市場策略、地理擴張、資本投資決策、法規結構及影響、新產品開發、競爭情報

報告範圍：

• 2022年至2024年的歷史數據和2025年至2030年的預測數據
• 成長機會、挑戰、供應鏈前景、法規結構與趨勢分析
• 競爭定位、策略和市場佔有率分析
• 按業務板塊和地區分類的收入成長和預測評估，包括國家/地區
• 公司概況（策略、產品、財務資訊、關鍵發展等）

目錄

第1章執行摘要

第2章 市場概覽

• 市場概覽
• 市場定義
• 調查範圍
• 市場區隔

第3章 商業情境

• 市場促進因素
• 市場限制
• 市場機遇
• 波特五力分析
• 產業價值鏈分析
• 政策與法規
• 策略建議

第4章 技術展望

5. 全球葡萄糖酸鈣市場（依形態分類）

• 介紹
• 固體的
• 液體

6. 全球葡萄糖酸鈣市場依給藥途徑分類

• 介紹
• 注射
• 口服

7. 全球葡萄糖酸鈣市場依應用領域分類

• 介紹
• 食品添加物
• 礦物質補充劑
• 皮膚調理劑
• 其他

8. 全球葡萄糖酸鈣市場（以最終用戶分類）

• 介紹
• 食品/飲料
• 製藥
• 個人護理及化妝品
• 其他

9. 全球葡萄糖酸鈣市場（按地區分類）

• 介紹
• 北美洲
  • 美國
  • 加拿大
  • 墨西哥
• 南美洲
  • 巴西
  • 阿根廷
  • 其他
• 歐洲
  • 德國
  • 法國
  • 英國
  • 西班牙
  • 其他
• 中東和非洲
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 以色列
  • 其他
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 印尼
  • 泰國
  • 其他

第10章 競爭格局與分析

• 主要企業和策略分析
• 市佔率分析
• 合併、收購、協議和合作
• 競爭對手儀錶板

第11章 公司簡介

• Spectrum Laboratory Products, Inc.
• Thermo Fisher Scientific
• Noah Technologies Corporation
• Global Calcium Pvt Ltd
• Merck KGaA
• Tomita Pharmaceutical Co., Ltd
• Shandong Xinhong Pharmaceutical Co., Ltd
• AdvaCare Pharma
• Paul Lohmann GmbH & Co. KGaA
• Jiaan Biotech
• Fresenius Kabi

第12章附錄

• 貨幣
• 先決條件
• 基準年和預測年時間表
• 相關人員的主要收益
• 調查方法
• 簡稱

Global Calcium Gluconate Market, with a 4.13% CAGR, is projected to grow to USD 156.023 million by 2030 from USD 127.471 million in 2025.

Calcium gluconate is a mineral supplement produced through the neutralization of gluconic acid with lime or calcium carbonate. It serves as a critical therapeutic agent, administered via intravenous therapy and other methods, to treat various conditions stemming from calcium deficiencies. These include hypocalcemic tetany, hypocalcemia associated with hyperparathyroidism, conditions related to rapid growth or pregnancy, and hypermagnesemia. The global market for calcium gluconate is projected to expand, driven by rising demand from key end-use sectors, particularly the pharmaceutical and food and beverage industries.

Market Growth Drivers

A primary driver for the calcium gluconate market is the increased consumption of nutritional supplements. The well-established benefits of calcium supplementation in managing deficient conditions such as hypocalcemia and its associated complications have solidified demand. Public health awareness regarding conditions like osteoporosis, which affects a significant portion of the population, is prompting individuals to proactively incorporate calcium supplements into their health regimens, thereby driving market growth for products like calcium gluconate.

While seemingly distinct, the consumption of other mineral supplements, such as copper gluconate, also influences the market landscape. Copper plays a vital role in physiological functions, including the maintenance of heart rate, and deficiencies have been linked to cardiac illnesses. As global cases of heart disease and other health issues related to poor nutrition and vitamin deficiencies rise, the overall market for mineral supplements expands. This trend, fueled by factors like the consumption of nutrient-poor junk food and rising eating disorders, indirectly boosts the demand for gluconate-based supplements, including calcium gluconate.

Furthermore, the strategic focus of key industry players on investments and collaborations is a significant market driver. Companies are channeling investments into acquiring new technologies, securing raw material supplies, and enhancing product portfolios to sustain growth in a competitive economic climate. Recognizing the varied economic and social landscapes across different countries, manufacturers are increasingly developing region-specific strategies to effectively penetrate diverse global markets.

Market Segment Analysis

In terms of product segments, calcium lactate gluconate is anticipated to hold a maximum market share. This compound is a white, crystalline, and odorless powder known for its high physiological compatibility and non-toxic nature. Its superior bioavailability, neutral taste, and excellent solubility make it a preferred choice. Scientifically, it has been shown to increase bone mineral density more consistently and significantly than other calcium salts. These properties make it particularly valuable as a premium calcium source in pharmaceuticals and for use in food processing applications where solubility is critical, such as in clear beverages and quick-dissolve formulations.

Regarding application, the pharmaceutical industry represents a significant domain for calcium gluconate. The advantages of calcium gluconate in medical treatments, especially for managing osteoporosis driven by changing lifestyles and physical inactivity, account for its largest market share. Additionally, the rising consumer demand for products aimed at preventing calcium deficiency is a key factor propelling its use in pharmaceutical applications.

Geographical Outlook

From a regional perspective, North America is anticipated to be a key marketplace for calcium gluconate globally. The expansion of the region's robust healthcare sector is the main driver. The presence of major pharmaceutical manufacturers and the production of medications for treating conditions like thyroid problems and rickets are specific factors propelling market growth in this region.

Concurrently, strategic investment programs in the United States are anticipated to propel further growth. Initiatives launched by health foundations and scientific academies are focused on addressing global calcium deficiency and its health impacts. These programs often explore the role of calcium supplementation in improving health outcomes, including maternal health and cardiovascular function. The established link between low calcium levels and an increased risk of cardiovascular disorders further underscores the importance of supplementation, thereby contributing to the growing market share for calcium gluconate as a key therapeutic and preventive agent.

Key Benefits of this Report:

• Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
• Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
• Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
• Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
• Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

• Historical data from 2022 to 2024 & forecast data from 2025 to 2030
• Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
• Competitive Positioning, Strategies, and Market Share Analysis
• Revenue Growth and Forecast Assessment of segments and regions including countries
• Company Profiling (Strategies, Products, Financial Information, and Key Developments among others.

Segmentation:

• GLOBAL CALCIUM GLUCONATE MARKET BY FORM TYPE
• Solid
• Liquid
• GLOBAL CALCIUM GLUCONATE MARKET BY MODE OF ADMINISTRATION
• Injectables
• Orals
• GLOBAL CALCIUM GLUCONATE MARKET BY APPLICATION
• Food Additives
• Mineral Supplements
• Skin Conditioning Agent
• Others
• GLOBAL CALCIUM GLUCONATE MARKET BY END-USER
• Food & Beverage
• Pharmaceuticals
• Personal Care & Cosmetics
• Others
• GLOBAL CALCIUM GLUCONATE MARKET BY GEOGRAPHY
• North America
• USA
• Canada
• Mexico
• South America
• Brazil
• Argentina
• Others
• Europe
• Germany
• France
• United Kingdom
• Spain
• Others
• Middle East and Africa
• Saudi Arabia
• UAE
• Israel
• Others
• Asia Pacific
• China
• India
• Japan
• South Korea
• Indonesia
• Thailand
• Others

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

• 2.1. Market Overview
• 2.2. Market Definition
• 2.3. Scope of the Study

2.4. Market Segmentation

3. BUSINESS LANDSCAPE

• 3.1. Market Drivers
• 3.2. Market Restraints
• 3.3. Market Opportunities
• 3.4. Porter's Five Forces Analysis
• 3.5. Industry Value Chain Analysis
• 3.6. Policies and Regulations
• 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. GLOBAL CALCIUM GLUCONATE MARKET BY FORM TYPE

• 5.1. Introduction
• 5.2. Solid
• 5.3. Liquid

6. GLOBAL CALCIUM GLUCONATE MARKET BY MODE OF ADMINISTRATION

• 6.1. Introduction
• 6.2. Injectables
• 6.3. Orals

7. GLOBAL CALCIUM GLUCONATE MARKET BY APPLICATION

• 7.1. Introduction
• 7.2. Food Additives
• 7.3. Mineral Supplements
• 7.4. Skin Conditioning Agent
• 7.5. Others

8. GLOBAL CALCIUM GLUCONATE MARKET BY END-USER

• 8.1. Introduction
• 8.2. Food & Beverage
• 8.3. Pharmaceuticals
• 8.4. Personal Care & Cosmetics
• 8.5. Others

9. GLOBAL CALCIUM GLUCONATE MARKET BY GEOGRAPHY

• 9.1. Introduction
• 9.2. North America
  • 9.2.1. USA
  • 9.2.2. Canada
  • 9.2.3. Mexico
• 9.3. South America
  • 9.3.1. Brazil
  • 9.3.2. Argentina
  • 9.3.3. Others
• 9.4. Europe
  • 9.4.1. Germany
  • 9.4.2. France
  • 9.4.3. United Kingdom
  • 9.4.4. Spain
  • 9.4.5. Others
• 9.5. Middle East and Africa
  • 9.5.1. Saudi Arabia
  • 9.5.2. UAE
  • 9.5.3. Israel
  • 9.5.4. Others
• 9.6. Asia Pacific
  • 9.6.1. China
  • 9.6.2. India
  • 9.6.3. Japan
  • 9.6.4. South Korea
  • 9.6.5. Indonesia
  • 9.6.6. Thailand
  • 9.6.7. Others

10. COMPETITIVE ENVIRONMENT AND ANALYSIS

• 10.1. Major Players and Strategy Analysis
• 10.2. Market Share Analysis
• 10.3. Mergers, Acquisitions, Agreements, and Collaborations
• 10.4. Competitive Dashboard

11. COMPANY PROFILES

• 11.1. Spectrum Laboratory Products, Inc.
• 11.2. Thermo Fisher Scientific
• 11.3. Noah Technologies Corporation
• 11.4. Global Calcium Pvt Ltd
• 11.5. Merck KGaA
• 11.6. Tomita Pharmaceutical Co., Ltd
• 11.7. Shandong Xinhong Pharmaceutical Co., Ltd
• 11.8. AdvaCare Pharma
• 11.9. Paul Lohmann GmbH & Co. KGaA
• 11.10. Jiaan Biotech
• 11.11. Fresenius Kabi

12. APPENDIX

• 12.1. Currency
• 12.2. Assumptions
• 12.3. Base and Forecast Years Timeline
• 12.4. Key Benefits for the Stakeholders
• 12.5. Research Methodology
• 12.6. Abbreviations